NEW YORK (

TheStreet

) -- Shares of

Questcor Pharmaceuticals

(Nasdaq:

QCOR

) were gapping up Wednesday morning with an open price 16.4% higher than Tuesday's closing price. The stock closed at $26 Tuesday and opened today's trading at $30.27.

The average volume for Questcor has been 898,800 shares per day over the past 30 days. Questcor has a market cap of $1.7 billion and is part of the

health care

sector and

drugs

industry. Shares are up 76.5% year to date as of the close of trading on Tuesday.

Questcor Pharmaceuticals, Inc., a pharmaceutical company, provides prescription drugs for central nervous system and inflammatory disorders. Its primary drug is H.P. The company has a P/E ratio of 45.6, below the average drugs industry P/E ratio of 46.4 and above the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Questcor as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. You can view the full

Questcor Ratings Report

.

Get more investment ideas from our

investment research center

.

Interested in other stocks that are gapping up? Get free SMS text alerts sent to you when the action happens by texting

UP

to 95370 or select from

multiple alert options

.

null